Yunnan Baiyao Group Co.,Ltd
000538
株式のランク
#1530
Operating globally and domestically within China, Yunnan Baiyao Group Co., Ltd.... Operating globally and domestically within China, Yunnan Baiyao Group Co., Ltd. specializes in the pharmaceutical industry. Its diverse portfolio encompasses health supplements, a wide array of medications, medical devices, traditional Chinese medicine ingredients, and even tea. These offerings are marketed under various brand identities, including Yunnan Baiyao, Yunfeng, Tong Qiaoqiao, Yunjian, Life, Jinkoujian, Langjian, Yangyuanqing, Caizhiji, Baiyao Health, Leopard Seven, Qiancaotang, Qiancao Meizi, and Tianzihong. The company, established in 1902, maintains its principal offices in Kunming, China.
株価
$7.90
最終同期: 2026-10-22
時価総額
$14.09B
変化（1日）
-0.13%
変化（1年）
-0.53%
国
CN
取引 Yunnan Baiyao Group Co.,Ltd (000538)
カテゴリー
Healthcare
Yunnan Baiyao Group Co.,Ltd（000538）の収益
Jun 2026 時点の収益 TTM: $6.25B
Yunnan Baiyao Group Co.,Ltd の最新の財務報告によると、現在の収益 (TTM) は $6.25B です。2024 年には $5.48B の収益があり、これは 2023 年の $5.53B と比較して 減少 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Yunnan Baiyao Group Co.,Ltd の収益履歴（2001 ～ 2026）
各年末の収益
| 年 | 収益 | 変化 |
|---|---|---|
| 2026 (TTM) | $6.25B | 6.25% |
| 2025 | $5.89B | 7.33% |
| 2024 | $5.48B | -0.73% |
| 2023 | $5.53B | 4.45% |
| 2022 | $5.29B | -7.57% |
| 2021 | $5.72B | 14.18% |
| 2020 | $5.01B | 17.65% |
| 2019 | $4.26B | 8.46% |
| 2018 | $3.93B | 5.10% |
| 2017 | $3.74B | 15.78% |
| 2016 | $3.23B | 1.07% |
| 2015 | $3.19B | 5.14% |
| 2014 | $3.04B | 16.50% |
| 2013 | $2.61B | 17.68% |
| 2012 | $2.22B | 23.46% |
| 2011 | $1.79B | 17.55% |
| 2010 | $1.53B | 45.31% |
| 2009 | $1.05B | 25.24% |
| 2008 | $838.74M | 48.80% |
| 2007 | $563.67M | 37.49% |
| 2006 | $409.97M | 35.16% |
| 2005 | $303.33M | 37.00% |
| 2004 | $221.41M | 36.25% |
| 2003 | $162.50M | 22.17% |
| 2002 | $133.01M | 22.26% |
| 2001 | $108.80M | 0.00% |
同業他社の収益
| 企業 | 収益 | 収益の差 | 国 |
|---|---|---|---|
| $23.54B | 276.26% |
DE
|
|
| $23.73B | 279.46% |
DE
|
|
| $29.24B | 367.46% |
JP
|
|
| $5.85B | -6.49% |
CH
|
|
| $6.34B | 1.40% |
IN
|
